XpresSpa Group

XWELL, Inc. provides global travel health and wellness services. It operates through the following segments: XpresSpa, XpresTest, Treat, and Corporate and Other. The XpresSpa segment offers travelers premium spa services, including massage, nail and skin care, as well as spa and travel products. The XpresTest segment deals with diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public. The Treat segment consists of access to integrated care which can seamlessly fit into a post-pandemic world and is designed to deliver on-demand access to integrated healthcare through technology and personalized services, positioned for a traveler to access health care, records and real-time information all in one place. The company was founded by Jonathan Medved and David Goldfarb on January 9, 2006 and is headquartered in New York, NY.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

XWELL, Inc. provides global travel health and wellness services. It operates through the following segments: XpresSpa, XpresTest, Naples Wax Center, Treat, and Corporate & Other. The XpresSpa segment offers travelers premium spa services, including massage, nail and skin care, as well as spa and travel products. The XpresTest segment deals with diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public. The Naples Wax Center segment is focused on the products and service offerings from face and body waxing to a range of skincare and cosmetic products. The Treat segment is a wellness brand that provides access to wellness services for travelers at on-site centers. The company was founded by Jonathan Medved and David Goldfarb on January 9, 2006 and is headquartered in New York, NY.

Newark Facility Expected to Commence Operations Mid-August

XpresSpa Group Signs Contract with the Port Authority of New York and New Jersey for an XpresCheck™ COVID-19 Testing Facility at Newark Liberty International Airport

With so many variables impacting XSPA stock, it’s difficult to know where the airport health and wellness center will end up. To get some clarity, investors should look at the math.

Is XpresSpa Group a Buy? The Math Says Yes!

With a vaccine potentially two or three months away, XpressSpa appears to be moving at a snail's pace, increasing the risk posed by XSPA stock.
The post XpresSpa Shares Are Facing More Problems appeared first on InvestorPlace.

XpresSpa Shares Are Facing More Problems

Ideanomics Inc

Electrameccanica

Tonix Pharmaceuticals Hld

Zomedica

Penny stocks will always be risky. That said, with the huge disconnect we're seeing in the markets, now may be a time to gamble.

The Top 8 Penny Stocks to Buy for August Uncertainty

Right now, XSPA stock doesn't make sense under any scenario. Speculative investments continue, but nothing is redeeming XpresSpa long-term.

XpresSpa Isn’t Worth Investor Money Regardless of Its Core Business

XpresSpa has a loaded balance sheet and tough business. That's why XSPA stock has been so volatile lately.

XpresSpa Stock Needs to Overcome Short-Term Troubles

Digital Ally Inc

Foresight Autonomous Hlds

iBio

NovaBay Pharmaceuticals

Exela Technologies

While penny stocks carry a high degree of risk, they could be a good place to look for value in today's market for investors that are willing to make short-term trades. These seven have potential catalysts on the horizon that make them worth considering.

7 Penny Stocks for the Valiant Investor

How did XpresSpa, on the verge of bankruptcy, raise $48 million from investors with its surprising coronavirus plan? And should prospective XSPA stock holders stay away?

XpresSpa’s Covid-19 Plan Fooled Investors. Now XSPA Stock Will Go to Zero

With air travel and consumer spending still nowhere near pre-coronavirus levels, XSPA stock is a risky idea, to put it mildly.
The post XpresSpa Is in a Tough Place With Covid-19 Still in Play appeared first on InvestorPlace.

XpresSpa Is in a Tough Place With Covid-19 Still in Play

XSPA stock can't be considered anything more than a speculative stock because the firm's future plans are flimsy at best.
The post XpresSpa Can’t Relax Regardless of the Pandemic’s Outcome appeared first on InvestorPlace.

XpresSpa Can’t Relax Regardless of the Pandemic’s Outcome

Say what you will about XpresSpa (NASDAQ:XSPA) pivoting from one business model to another but the future of XSPA stock depends on it.  
The post Here Are the Reasons XpresSpa Stock Could Be Worth the Gamble appeared first on InvestorPlace.

Here Are the Reasons XpresSpa Stock Could Be Worth the Gamble

AMC Entertainment

Genius Brands

A multiplex operator, an animated entertainment upstart, and an airport services provider have risks as high as their share prices are low.

3 Stocks Under $5 to Avoid

XpresSpa's unproftiable niche business was ravaged by the pandemic. Now XSPA stock is trying to rally as the company attempts a difficult, confusing pivot.

XSPA Stock Needs More Than a Great Story to Be a Compelling Investment

The airport screening angle makes XSPA stock interesting, but it's rarely a good sign when there's a reverse split.
The post Find Another Covid Investment Than XpresSpa Stock appeared first on InvestorPlace.

Find Another Covid Investment Than XpresSpa Stock

XpresSpa deserves all the credit in the world for attacking the coronavirus head on. But that alone won’t maintain momentum for XSPA stock.

XpresSpa Is Bold, but Can It Be Profitable?

XpresSpa's previous business model wasn't working. But as a Covid-19 testing center, XSPA stock is a much more interesting play.

The Key to XpresSpa’s Growth Will Be Its Scalability

The specialist airport spa retailer is being cautious about where its newly-created XpresCheck brand might go next.

XpresSpa Warns That New Covid-19 Testing Service May Have A Limited Rollout

So, what's the play? Don't go long XSPA stock, as the company's coronavirus catalyst isn't as strong as it seems.

Despite Its Coronavirus Catalyst, XpresSpa Stock Is Too Hyped to Touch

XpresSpa Group, Inc. (NASDAQ: XSPA) shares are trading higher after the company announced Monday afternoon it significantly strengthened its balance sheet through recent capital raises and debt reduction and that it launched COVID-19 testing at JFK on June 22nd.

Why XpresSpa's Stock Is Trading Higher Today

Unless airport passenger numbers show consistent growth and revenue levels improve, XSPA stock cannot create shareholder value.
The post XpresSpa Doesn’t Look Any Better After Its Reverse Split appeared first on InvestorPlace.

XpresSpa Doesn’t Look Any Better After Its Reverse Split

Significantly Strengthened Balance Sheet through Recent Capital Raises and Debt Reduction   Launched COVID-19 Testing at JFK International Airport on June 22nd   Files SEC Form 10-Q for the First Quarter ending March 31, 2020

XpresSpa Group Provides Business Update

Sure, XpresSpa made a pretty significant pivot at the start of the pandemic. But for bulls, the pivot creates a nice opportunity in XSPA stock.

You Can Breathe Easy With XpresSpa Stock

XpresCheck Pilots Nation’s First Full Service, In-Airport, Testing Facility with JFKIAT and Port Authority

XpresSpa Group Announces the Opening of the XpresCheck™ Pilot Program for Airport Employees at JFK International Airport’s Terminal 4; The First Full Service, In-Airport, Testing Facility in the U.S.

XpresSpa has no experience in the field it's trying to enter, it's getting a late start, and it;s facing competitors that are giving away the service. The outlook of XSPA stock is negative.

Getting Into the Testing Business May Spell Disaster for XpresSpa Stock

XpresSpa is a lesson in how companies can turn lemon into lemonade. But once everything normalizes, the original business underlining XSPA stock will be worth a look.

News for XpresSpa Group Stock (XSPA)